Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer
BackgroundProstate cancer (PCa) is an age-associated malignancy with high morbidity and mortality rate, posing a severe threat to public health. Cellular senescence, a specialized cell cycle arrest form, results in the secretion of various inflammatory mediators. In recent studies, senescence has sh...
Main Authors: | Chenglin Han, Yuxuan Deng, Bin Yang, Peng Hu, Bintao Hu, Tao Wang, Jihong Liu, Qidong Xia, Xiaming Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1126902/full |
Similar Items
-
Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment
by: Bintao Hu, et al.
Published: (2024-01-01) -
Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment
by: Qing Liu, et al.
Published: (2023-02-01) -
Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01) -
Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
by: Junsheng Li, et al.
Published: (2022-10-01) -
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
by: Jianming Lu, et al.
Published: (2023-07-01)